133 related articles for article (PubMed ID: 19718045)
1. The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis.
Baum N; Schiene-Fischer C; Frost M; Schumann M; Sabapathy K; Ohlenschläger O; Grosse F; Schlott B
Oncogene; 2009 Nov; 28(44):3915-25. PubMed ID: 19718045
[TBL] [Abstract][Full Text] [Related]
2. p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme.
Wiseman A
Med Hypotheses; 2005; 65(1):32-4. PubMed ID: 15893113
[TBL] [Abstract][Full Text] [Related]
3. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis.
Bernal JA; Luna R; Espina A; Lázaro I; Ramos-Morales F; Romero F; Arias C; Silva A; Tortolero M; Pintor-Toro JA
Nat Genet; 2002 Oct; 32(2):306-11. PubMed ID: 12355087
[TBL] [Abstract][Full Text] [Related]
4. The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning.
Golubovskaya VM; Finch R; Zheng M; Kurenova EV; Cance WG
Biochem J; 2008 Apr; 411(1):151-60. PubMed ID: 18215142
[TBL] [Abstract][Full Text] [Related]
5. Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.
Christian KJ; Lang MA; Raffalli-Mathieu F
Mol Pharmacol; 2008 May; 73(5):1558-67. PubMed ID: 18296503
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
7. Chaperone activity of Cyp18 through hydrophobic condensation that enables rescue of transient misfolded molten globule intermediates.
Moparthi SB; Fristedt R; Mishra R; Almstedt K; Karlsson M; Hammarström P; Carlsson U
Biochemistry; 2010 Feb; 49(6):1137-45. PubMed ID: 20070121
[TBL] [Abstract][Full Text] [Related]
8. p53 Is Potentially Regulated by Cyclophilin D in the Triple-Proline Loop of the DNA Binding Domain.
Kumutima J; Yao XQ; Hamelberg D
Biochemistry; 2021 Mar; 60(8):597-606. PubMed ID: 33591178
[TBL] [Abstract][Full Text] [Related]
9. Folding of barstar C40A/C82A/P27A and catalysis of the peptidyl-prolyl cis/trans isomerization by human cytosolic cyclophilin (Cyp18).
Golbik R; Fischer G; Fersht AR
Protein Sci; 1999 Jul; 8(7):1505-14. PubMed ID: 10422840
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
Bauer K; Kretzschmar AK; Cvijic H; Blumert C; Löffler D; Brocke-Heidrich K; Schiene-Fischer C; Fischer G; Sinz A; Clevenger CV; Horn F
Oncogene; 2009 Aug; 28(31):2784-95. PubMed ID: 19503092
[TBL] [Abstract][Full Text] [Related]
11. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
[TBL] [Abstract][Full Text] [Related]
13. The interaction of the hnRNP family member E1B-AP5 with p53.
Barral PM; Rusch A; Turnell AS; Gallimore PH; Byrd PJ; Dobner T; Grand RJ
FEBS Lett; 2005 May; 579(13):2752-8. PubMed ID: 15907477
[TBL] [Abstract][Full Text] [Related]
14. TOE1 interacts with p53 to modulate its transactivation potential.
Sperandio S; Tardito S; Surzycki A; Latterich M; de Belle I
FEBS Lett; 2009 Jul; 583(13):2165-70. PubMed ID: 19508870
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
[TBL] [Abstract][Full Text] [Related]
16. S100A6 binds p53 and affects its activity.
Słomnicki ŁP; Nawrot B; Leśniak W
Int J Biochem Cell Biol; 2009 Apr; 41(4):784-90. PubMed ID: 18765292
[TBL] [Abstract][Full Text] [Related]
17. Identification of a function-specific mutation of clathrin heavy chain (CHC) required for p53 transactivation.
Ohata H; Ota N; Shirouzu M; Yokoyama S; Yokota J; Taya Y; Enari M
J Mol Biol; 2009 Dec; 394(3):460-71. PubMed ID: 19766654
[TBL] [Abstract][Full Text] [Related]
18. A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway.
Li C; Chen H; Ding F; Zhang Y; Luo A; Wang M; Liu Z
Biochem J; 2009 Aug; 422(2):363-72. PubMed ID: 19534726
[TBL] [Abstract][Full Text] [Related]
19. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
[TBL] [Abstract][Full Text] [Related]
20. Interaction of metallothionein with tumor suppressor p53 protein.
Ostrakhovitch EA; Olsson PE; Jiang S; Cherian MG
FEBS Lett; 2006 Feb; 580(5):1235-8. PubMed ID: 16442532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
